NCT05479786

Brief Summary

Although ectopic pregnancy was considered a leading cause of first-trimester maternal mortalities, current technological improvements allowed early diagnosis and opened a door for applying less invasive approaches. A tubal pregnancy could be managed either expectantly, medically, or surgically. The expectant management of ectopic pregnancy relies on the fact that a considerable proportion of ectopic gestations terminate by spontaneous tubal abortion. This approach is usually kept for stable cases with a small gestational sac and low beta-human chorionic gonadotropin (beta-HCG) serum levels. For hemodynamically unstable patients, higher levels of beta-HCG, and larger gestational sacs, surgery is often considered as the treatment of choice (16). Considering this background, the study aims to analyze the subsequent natural reproductive outcomes of patients that had a previous tubal ectopic pregnancy and were managed either expectantly or surgically. Moreover, it amis to determine the factors that could influence the fertility potential of these patients in each treatment group.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
312

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 29, 2022

Completed
Last Updated

August 2, 2022

Status Verified

July 1, 2022

Enrollment Period

9 years

First QC Date

July 26, 2022

Last Update Submit

July 28, 2022

Conditions

Keywords

Ectopic pregnancyExpectant managementPregnancy outcomeSalpingectomySalpingostomy

Outcome Measures

Primary Outcomes (1)

  • Clinical pregnancy rate

    Presence of a gestational sac under ultrasonography

    Within one year after the previous episode of tubal ectopic pregnancy

Study Arms (1)

Ectopic pregnancy

Women with diagnosed tubal ectopic pregnancy

Other: Expectant managementProcedure: SalpingectomyProcedure: Salpingostomy

Interventions

Follow-up with beta-HCG dosages and transvaginal ultrasound scans

Ectopic pregnancy
SalpingectomyPROCEDURE

Removal of the affected Fallopian tube by laparoscopy

Ectopic pregnancy
SalpingostomyPROCEDURE

Removal of the ectopic pregnancy from the Fallopian tube, without removing the whole Fallopian tube, by laparoscopy

Ectopic pregnancy

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women with either surgically-confirmed tubal ectopic pregnancy or a diagnosis of tubal ectopic pregnancy based on a positive beta-HCG serum measurement with the visualization of an adnexal mass resembling a tubal gestational sac and an empty uterine cavity upon transvaginal ultrasonographic scan.

You may qualify if:

  • Women with one episode of tubal ectopic pregnancy, treated by expectant management, salpingectomy, or salpingostomy;
  • For patients treated surgically, only patients with at least one patent Fallopian tube confirmed via postoperative hysterosalpingography were included in the analysis.

You may not qualify if:

  • Pregnancies of unknown location
  • Other types of ectopic pregnancy
  • Pelvic inflammatory disease
  • Pelvic adhesions
  • Intrauterine pathologies
  • Pregnancies obtained after assisted-reproductive technologies (ART)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pregnancy, Ectopic

Interventions

Watchful WaitingSalpingectomySalpingostomy

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

Outcome Assessment, Health CareOutcome and Process Assessment, Health CareQuality of Health CareHealth Services AdministrationGynecologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, OperativeAnastomosis, Surgical

Study Officials

  • Antonio Simone Laganà, M.D., Ph.D.

    University of Palermo

    PRINCIPAL INVESTIGATOR
  • Antoine Naem, M.D.

    Damascus University

    STUDY CHAIR
  • Péter Török, M.D.

    University of Debrecen

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 26, 2022

First Posted

July 29, 2022

Study Start

January 1, 2012

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

August 2, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share